1. Home
  2. MDXH vs JYNT Comparison

MDXH vs JYNT Comparison

Compare MDXH & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$2.29

Market Cap

149.0M

Sector

N/A

ML Signal

HOLD

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.66

Market Cap

120.7M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDXH
JYNT
Founded
2003
2010
Country
Belgium
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
149.0M
120.7M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
MDXH
JYNT
Price
$2.29
$8.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$7.67
$17.00
AVG Volume (30 Days)
210.3K
32.2K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
133.93
EPS
N/A
0.19
Revenue
N/A
$117,696,356.00
Revenue This Year
$30.78
$12.23
Revenue Next Year
$18.31
N/A
P/E Ratio
N/A
$45.71
Revenue Growth
N/A
15.49
52 Week Low
$1.67
$7.50
52 Week High
$5.33
$13.47

Technical Indicators

Market Signals
Indicator
MDXH
JYNT
Relative Strength Index (RSI) 40.67 47.53
Support Level $1.93 $8.46
Resistance Level $2.75 $9.47
Average True Range (ATR) 0.18 0.33
MACD 0.05 -0.01
Stochastic Oscillator 80.54 19.89

Price Performance

Historical Comparison
MDXH
JYNT

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: